Pharma marketers are contending with regulatory whiplash and rising public mistrust under the Trump administration, forcing shifts in media strategy and creative approaches.

Six former U.S. surgeon generals wrote an op-ed, warning the public about HHS Robert F. Kennedy Jr. In the op-ed, they stated that Kennedy is “endangering the health of the nation,” noting that never before have all six come together to issue a statement like this. ( Axios )

This story is part of Forbes’ coverage of India’s Richest 2025. See the full list here.

Eli Lilly (LLY 0.99%) is the most valuable healthcare stock in the world, with a market capitalization of more than $760 billion. It has been soaring in recent years due to the su

Roche Holding and AstraZeneca were among those companies posting increases as European pharma stocks tracked gains in the U.S. on Tuesday.

EXECUTIVE CHAIRMAN & CEO OF MEDICUS TO PARTICIPATE IN A PANEL DISCUSSION The Summit theme “unlocking the $1 Trillion Wealth transfer in Dubai” PHILADELPHIA, PENNSYLVANIA / ACCESS Newswire / October 7,

Indian firm Natco Pharma is set to acquire substantial stakes in South African pharmaceutical company Adcock Ingram. This deal, valued at R4.2 billion, will transition Adcock Ingram into a privately held company.

The pharmaceutical company is one of the honorees on the Fortune 100 Best Companies to Work For Europe list in 2025.

Speculation about succession at Sun Pharmaceutical Industries, India’s most valuable drug maker, was put to rest this year when its billionaire founder, Dilip Shanghvi, made some changes at the top.